Literature DB >> 22593009

Validity of the Generalized Anxiety Disorder-7 scale in an acute psychiatric sample.

Sarah Kertz1, Joe Bigda-Peyton, Throstur Bjorgvinsson.   

Abstract

UNLABELLED: Generalized anxiety disorder (GAD) is one of the most prevalent psychiatric presentations; however, GAD has the lowest diagnostic reliability of the anxiety disorders and is poorly recognized in clinical practice. A more reliable assessment of GAD could lead to earlier detection and treatment of the disorder, which has an otherwise debilitating course and significant associated impairment. The 7-item GAD Scale (GAD-7) has shown promise as a measure with good clinical utility and strong psychometric properties in primary care and community settings but has yet to be assessed in acute psychiatric populations. This study examined the validity of the GAD-7 in a sample of 232 patients enrolled in a partial hospital programme. Patients completed a diagnostic interview and a battery of self-report measures before and after treatment. Findings suggest that the GAD-7 has good internal consistency and good convergent validity with worry, anxiety, depression and stress, and the measure was sensitive to change over the course of a short intensive cognitive-behavioural therapy partial hospital programme. However, the confirmatory analysis failed to support the hypothesized unidimensional factor structure; and although the GAD-7 demonstrated good sensitivity (.83), specificity was poor (.46) in identifying patients with GAD. Overall, the GAD-7 appears to be a valid measure of generalized anxiety symptoms in this sample, on the basis of good internal consistency, convergent validity and sensitivity to change, but does not perform well as a screener for GAD. KEY PRACTITIONER MESSAGE: The GAD-7 Scale is an easy-to-score, self-report measure of core generalized anxiety disorder symptoms. The GAD-7 Scale has good internal consistency and convergent validity with depression, anxiety, stress and worry, and is sensitive to change. The GAD-7 Scale appears to be a good measure of generalized anxiety symptoms in an acute psychiatric sample. The GAD-7 Scale does not perform well as a screener for GAD and should not be used to identify cases of GAD in acute psychiatric samples.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Keywords:  GAD-7; Generalized Anxiety Disorder; Psychometric Properties; Worry

Mesh:

Year:  2012        PMID: 22593009     DOI: 10.1002/cpp.1802

Source DB:  PubMed          Journal:  Clin Psychol Psychother        ISSN: 1063-3995


  57 in total

1.  Psychometric Properties of the Generalized Anxiety Disorder Scale-7 (GAD-7) in Outpatients with Anxiety and Mood Disorders.

Authors:  Lauren A Rutter; Timothy A Brown
Journal:  J Psychopathol Behav Assess       Date:  2016-09-10

2.  Free, brief, and validated: Standardized instruments for low-resource mental health settings.

Authors:  Rinad S Beidas; Rebecca E Stewart; Lucia Walsh; Steven Lucas; Margaret Mary Downey; Kamilah Jackson; Tara Fernandez; David S Mandell
Journal:  Cogn Behav Pract       Date:  2015-02-01

3.  Trauma, PTSD, and complex PTSD in the Republic of Ireland: prevalence, service use, comorbidity, and risk factors.

Authors:  Philip Hyland; Frédérique Vallières; Marylène Cloitre; Menachem Ben-Ezra; Thanos Karatzias; Miranda Olff; Jamie Murphy; Mark Shevlin
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2020-07-06       Impact factor: 4.328

4.  The 7-item generalized anxiety disorder scale as a tool for measuring generalized anxiety in multiple sclerosis.

Authors:  Alexandra L Terrill; Narineh Hartoonian; Meghan Beier; Rana Salem; Kevin Alschuler
Journal:  Int J MS Care       Date:  2015 Mar-Apr

5.  The bidirectional relationship between sleep complaints and pain: Analysis of data from a randomized trial.

Authors:  Erin Koffel; Kurt Kroenke; Matthew J Bair; David Leverty; Melissa A Polusny; Erin E Krebs
Journal:  Health Psychol       Date:  2015-06-15       Impact factor: 4.267

6.  Test Performance Characteristics of the AIR, GAD-7, and HADS-Anxiety Screening Questionnaires for Anxiety in Chronic Obstructive Pulmonary Disease.

Authors:  Anna M Baker; Janet T Holbrook; Abebaw M Yohannes; Michelle N Eakin; Elizabeth A Sugar; Robert J Henderson; Anne S Casper; David A Kaminsky; Alexis L Rea; Anne M Mathews; Loretta G Que; Joe W Ramsdell; Lynn B Gerald; Robert A Wise; Nicola A Hanania
Journal:  Ann Am Thorac Soc       Date:  2018-08

7.  Screening Tools for Anxiety in People with Multiple Sclerosis: A Systematic Review.

Authors:  Brittany Litster; Kirsten M Fiest; Scott B Patten; John D Fisk; John R Walker; Lesley A Graff; James M Bolton; Jitender Sareen; James J Marriott; Lindsay I Berrigan; Charles N Bernstein; Ryan Zarychanski; Alexander Singer; Carol A Hitchon; Christine A Peschken; Ruth Ann Marrie
Journal:  Int J MS Care       Date:  2016 Nov-Dec

8.  Stress and anxiety among physicians during the COVID-19 outbreak in the Iraqi Kurdistan Region: An online survey.

Authors:  Banaz A Saeed; Nazar P Shabila; Aram Jalal Aziz
Journal:  PLoS One       Date:  2021-06-29       Impact factor: 3.240

9.  Lessons learned from service design of a trial of a digital mental health service: Informing implementation in primary care clinics.

Authors:  Andrea K Graham; Carolyn J Greene; Thomas Powell; Pauli Lieponis; Amanda Lunsford; Chris D Peralta; L Casey Orr; Susan M Kaiser; Nameyeh Alam; Helom Berhane; Ozan Kalan; David C Mohr
Journal:  Transl Behav Med       Date:  2020-08-07       Impact factor: 3.046

10.  Validation of clinical symptom IRT scores for diagnosis and severity assessment of common mental disorders.

Authors:  Elena Olariu; José-Ignacio Castro-Rodriguez; Pilar Álvarez; Carolina Garnier; Marta Reinoso; Luis Miguel Martín-López; Jordi Alonso; Carlos G Forero
Journal:  Qual Life Res       Date:  2014-10-04       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.